Literature DB >> 10448

Glutathione and gamma glutamyl transpeptidase in rat liver during chemical carcinogenesis.

S Fiala, A Mohindru, W G Kettering, A E Fiala, H P Morris.   

Abstract

Continued administration of several hepatocarcinogens led to an increase in the concentration of glutathione (GSH) in the livers of intact, but not of hypophysectomized or adrenalectomized rats. The concentration of GSH remained high untill the development of hyperplastic nodules. Subsequently, the concentration of GSH dropped to the normal level or below. A single dose of 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB) produced an increase of GSH which, within a certain range, depended upon the amount of the carcinogen. In well differentiated, slowly growing hepatomas, the concentration of GSH approached the level in normal adult rat liver. On the other hand, in nondifferentiated and rapidly growing hepatomas, GSH was only 30-40% of that in normal liver. The activity of gamma-glutamyl transpeptidase (GTase) increased within 24-48 hours after a single large dose of 3'-Me-DAB. Continued feeding of 3'-Me-DAB led to an exponential increase of GTase. During hepatocarcinogenesis, the level of GTase activity corresponded to the degree and size of pathologic changes produced in rat liver. Chloramphenicol partially inhibited the increase of GTase induced by 2-acetylaminofluorene. Pretreatment with 3-methylcholanthrene partially inhibited the increase of GTase that had been induced by a single dose of 3'-Me-DAB. Puromycin partially inhibited the increase of GTase induced by several doses of dimethylnitrosamine. These observations indicated a close connection between the activation of GTase and chemical carcinogenesis in rat liver. Measurements of GTase activity in 12 Morris hepatomas supported this conclusion; their GTase levels were greatly elevated compared with that in normal adult rat liver.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 10448     DOI: 10.1093/jnci/57.3.591

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  21 in total

1.  The first normal oral mucosa epithelium in which gamma-glutamyl transpeptidase activity has been detected.

Authors:  A E Schwint; A M Collet; A E Mendez; R L Cabrini; M E Itoiz
Journal:  Histochem J       Date:  1992-12

2.  The stability of events in the natural history of neoplasia.

Authors:  H C Pitot
Journal:  Am J Pathol       Date:  1977-12       Impact factor: 4.307

3.  Identification, sequence, and expression of the gene encoding gamma-glutamyltranspeptidase in Bacillus subtilis.

Authors:  K Xu; M A Strauch
Journal:  J Bacteriol       Date:  1996-07       Impact factor: 3.490

4.  The natural history of neoplasia. Newer insights into an old problem.

Authors:  H C Pitot
Journal:  Am J Pathol       Date:  1977-11       Impact factor: 4.307

Review 5.  gamma-Glutamyltranspeptidase: a tumour cell marker with a pharmacological function.

Authors:  M Vanderlaan; W Phares
Journal:  Histochem J       Date:  1981-09

6.  Glutathione and GSH-dependent enzymes in the human gastric mucosa.

Authors:  R Hoppenkamps; E Thies; M Younes; C P Siegers
Journal:  Klin Wochenschr       Date:  1984-02-15

7.  Glutathione and GSH-dependent enzymes in the tumorous and nontumorous mucosa of the human colon and rectum.

Authors:  C P Siegers; H Böse-Younes; E Thies; R Hoppenkamps; M Younes
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

Review 8.  Enzymes of glutathione metabolism as biochemical markers during hepatocarcinogenesis.

Authors:  S Hendrich; H C Pitot
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

9.  Enzyme patterns in human hepatocellular carcinoma.

Authors:  M A Gerber; S N Thung
Journal:  Am J Pathol       Date:  1980-02       Impact factor: 4.307

10.  High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis.

Authors:  A K Godwin; A Meister; P J O'Dwyer; C S Huang; T C Hamilton; M E Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.